AmgenBlackLogo 1

For US Healthcare Professionals

You are now leaving www.IgG4Related.com

Amgen is not responsible for the content of external websites linked within www.IgG4Related.com. Do you want to continue?

Yes No

Uncontrolled symptoms are common, with ~54% of patients experiencing moderate-to-severe symptoms despite being on treatment2

Patients experience unpredictable fluctuations in symptoms, triggered by factors such as weather, diet, stress, and life events3

Woman standing with her arms crossed image

In a survey of 456 patients with myasthenia gravis (MG), patients reported an average of 5 ongoing symptoms. Among the most common were:2

Ocular myasthenia (53%)

Ptosis contained iconPtosis (49%)
Diplopia contained iconDiplopia (31%)
Weakness in arms iconWeakness in the arms (37%)
Fatigue contained 2 iconGeneral fatigue (47%)
17.6% of patients with MG

were working only part time and 5.7% were on long-term sick leave despite 92.5% of them receiving treatment.2,*


*From a physician-reported survey of 456 patients living with MG with a mean time since diagnosis of 43 months.

Image of a male patient impacted by gMG

Next

Explore treatment goals
  • References

    1. Meisel A, Saccà F, Spillane J, Vissing J; MG Collegium Sub‐committee. Eur J Neurol. 2024;31:e16280.

    2. Mahic M, Bozorg AM, DeCourcy JJ, et al. Neurol Ther. 2022;11:1535-1551.

    3. Jackson K, Parthan A, Lauher-Charest M, Broderick L, Law N, Barnett C. Neurol Ther. 2023;12:107-128.